Search Results - "MOLLNES, T. E"

Refine Results
  1. 1

    Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study by Eagan, T. M. L, Ueland, T, Wagner, P. D, Hardie, J. A, Mollnes, T. E, Damas, J. K, Aukrust, P, Bakke, P. S

    Published in The European respiratory journal (01-03-2010)
    “…Chronic obstructive pulmonary disease (COPD) is considered an inflammatory pulmonary disorder with systemic inflammatory manifestations. The aim of this study…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation by HARBOE, M., ULVUND, G., VIEN, L., FUNG, M., MOLLNES, T. E.

    Published in Clinical and experimental immunology (01-12-2004)
    “…SUMMARY Complement activation with formation of biologically potent mediators like C5a and the terminal C5b‐9 complex (TCC) contributes essentially to…”
    Get full text
    Journal Article
  4. 4

    Innate Immune Responses to Danger Signals in Systemic Inflammatory Response Syndrome and Sepsis by Castellheim, A, Brekke, O.-L, Espevik, T, Harboe, M, Mollnes, T.E

    Published in Scandinavian journal of immunology (01-06-2009)
    “…The systemic immune response induced by non-infectious agents is called systemic inflammatory response syndrome (SIRS) and infection-induced systemic immune…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission by Volokhina, E. B., Westra, D., van der Velden, T. J. A. M., van de Kar, N. C. A. J., Mollnes, T. E., van den Heuvel, L. P.

    Published in Clinical and experimental immunology (01-08-2015)
    “…Summary Atypical haemolytic uraemic syndrome (aHUS) is associated with (genetic) alterations in alternative complement pathway. Nevertheless, comprehensive…”
    Get full text
    Journal Article
  7. 7

    Heparin‐coated cardiopulmonary bypass circuits selectively deplete the pattern recognition molecule ficolin‐2 of the lectin complement pathway in vivo by Hein, E., Munthe‐Fog, L., Thiara, A. S., Fiane, A. E., Mollnes, T. E., Garred, P.

    Published in Clinical and experimental immunology (01-02-2015)
    “…Summary The complement system can be activated via the lectin pathway by the recognition molecules mannose‐binding lectin (MBL) and the ficolins. Ficolin‐2…”
    Get full text
    Journal Article
  8. 8

    Intracellular Complement Component 3 Attenuated Ischemia-Reperfusion Injury in the Isolated Buffer-Perfused Mouse Heart and Is Associated With Improved Metabolic Homeostasis by Torp, M-K, Ranheim, T, Schjalm, C, Hjorth, M, Heiestad, C M, Dalen, K T, Nilsson, P H, Mollnes, T E, Pischke, S E, Lien, E, Vaage, J, Yndestad, A, Stensløkken, K-O

    Published in Frontiers in immunology (01-04-2022)
    “…The innate immune system is rapidly activated during myocardial infarction and blockade of extracellular complement system reduces infarct size. Intracellular…”
    Get full text
    Journal Article
  9. 9

    Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA by Seelen, M.A., Roos, A., Wieslander, J., Mollnes, T.E., Sjöholm, A.G., Wurzner, R., Loos, M., Tedesco, F., Sim, R.B., Garred, P., Alexopoulos, E., Turner, M.W., Daha, M.R.

    Published in Journal of immunological methods (2005)
    “…Primary defence against invading microorganisms depends on a functional innate immune system and the complement system plays a major role in such immunity…”
    Get full text
    Journal Article
  10. 10

    Atrial Fibrillation: Inflammation in Disguise? by Lappegård, K. T., Hovland, A., Pop, G. A. M., Mollnes, T. E.

    Published in Scandinavian journal of immunology (01-08-2013)
    “…Atrial fibrillation is highly prevalent, and affected patients are at an increased risk of a number of complications, including heart failure and…”
    Get full text
    Journal Article
  11. 11

    LDL Apheresis and Inflammation - Implications for Atherosclerosis by Hovland, A., Lappegård, K. T., Mollnes, T. E.

    Published in Scandinavian journal of immunology (01-09-2012)
    “…Low‐density lipoprotein (LDL) apheresis is an extracorporeal treatment modality used in high‐risk patients when LDL cholesterol levels cannot be reduced…”
    Get full text
    Journal Article
  12. 12

    The key roles of complement and tissue factor in Escherichia coli‐induced coagulation in human whole blood by Landsem, A., Fure, H., Christiansen, D., Nielsen, E. W., Østerud, B., Mollnes, T. E., Brekke, O. L.

    Published in Clinical and experimental immunology (01-10-2015)
    “…Summary The complement system and the Toll‐like (TLR) co‐receptor CD14 play important roles in innate immunity and sepsis. Tissue factor (TF) is a key…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis by Søyland, E., Heier, I., Rodríguez-Gallego, C., Mollnes, T.E., Johansen, F.-E., Holven, K.B., Halvorsen, B., Aukrust, P., Jahnsen, F.L., de la Rosa Carrillo, D., Krogstad, A.-L., Nenseter, M.S.

    Published in British journal of dermatology (1951) (01-02-2011)
    “…Summary Background  Ultraviolet (UV) radiation has immunosuppressive effects and heliotherapy is a well‐described treatment modality for psoriasis. Objectives …”
    Get full text
    Journal Article
  15. 15

    Systemic complement activation following human acute ischaemic stroke by PEDERSEN, E D., WAJE‐ANDREASSEN, U., VEDELER, C. A., AAMODT, G., MOLLNES, T. E.

    Published in Clinical and experimental immunology (01-07-2004)
    “…SUMMARY The brain tissue damage after stroke is mediated partly by inflammation induced by ischaemia–reperfusion injury where the complement system plays a…”
    Get full text
    Journal Article
  16. 16

    Systemic inflammation in acute intermittent porphyria: a case–control study by Storjord, E., Dahl, J. A., Landsem, A., Fure, H., Ludviksen, J. K., Goldbeck‐Wood, S., Karlsen, B. O., Berg, K. S., Mollnes, T. E., W. Nielsen, E., Brekke, O.‐L.

    Published in Clinical and experimental immunology (01-03-2017)
    “…Summary This study aimed to examine whether acute intermittent porphyria (AIP) is associated with systemic inflammation and whether the inflammation correlates…”
    Get full text
    Journal Article
  17. 17

    Inflammatory response induced by candidate biomaterials of an implantable microfabricated sensor by Sokolov, A., Hellerud, B. C., Johannessen, E. A., Mollnes, T. E.

    “…The implantation of synthetic medical devices is known to generate an immediate and complex material‐related inflammatory response. Consequently, 15 candidate…”
    Get full text
    Journal Article
  18. 18

    A novel method for direct measurement of complement convertases activity in human serum by Blom, A. M., Volokhina, E. B., Fransson, V., Strömberg, P., Berghard, L., Viktorelius, M., Mollnes, T. E., López‐Trascasa, M., Heuvel, L. P., Goodship, T. H., Marchbank, K. J., Okroj, M.

    Published in Clinical and experimental immunology (01-10-2014)
    “…Summary Complement convertases are enzymatic complexes that play a central role in sustaining and amplification of the complement cascade. Impairment of…”
    Get full text
    Journal Article
  19. 19

    Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus by Garabet, L., Gilboe, I.‐M., Mowinckel, M.‐C., Jacobsen, A. F., Mollnes, T. E., Sandset, P. M., Jacobsen, E.‐M.

    Published in Scandinavian journal of immunology (01-08-2016)
    “…Complement activation and low complement levels are common in systemic lupus erythematosus (SLE). Antiphospholipid antibodies (aPL) are found in about 30‐40%…”
    Get full text
    Journal Article
  20. 20

    Activation of coagulation and platelets by candidate membranes of implantable devices in a whole blood model without soluble anticoagulant by Sokolov, A., Hellerud, B. C., Tønnessen, T. I., Johannessen, E. A., Mollnes, T. E.

    “…Implantable devices are challenged with thrombus formation at their biomaterial interface. Thus the importance of identifying compatible biomaterials that will…”
    Get full text
    Journal Article